Binder Adam F, Handley Nathan R, Wilde Lindsay, Palmisiano Neil, Lopez Ana Maria
Department of Oncology, Sidney Kimmel Cancer Center, Thomas Jefferson University Hospital, Philadelphia, PA, United States.
Front Oncol. 2020 Jun 26;10:1183. doi: 10.3389/fonc.2020.01183. eCollection 2020.
In late January 2020, Severe Acute Respiratory Syndrome Coronavirus-2 (SARS CoV-2) was reported as an outbreak in Wuhan, China. Within 2 months it became a global pandemic. Patients with cancer are at highest risk for both contracting and suffering complications of its resultant disease, Coronavirus 19 (COVID-19). Healthcare systems across the world had to adapt quickly to mitigate this risk, while continuing to provide potentially lifesaving treatment to patients. Bringing care to the home through the use of telehealth, home based chemotherapy, and remote patient monitoring technologies can help minimize risk to the patient and healthcare workers without sacrificing quality of care delivered. These care models provide the right treatment, to the right patient, at the right time, . Whether these patient-centered models of care will continue to be embraced by key stakeholders after the pandemic remains uncertain.
2020年1月底，严重急性呼吸综合征冠状病毒2（SARS-CoV-2）在中国武汉爆发。在两个月内，它演变成了一场全球大流行。癌症患者感染其所致疾病新型冠状病毒肺炎（COVID-19）并出现并发症的风险最高。世界各地的医疗系统必须迅速做出调整以降低这种风险，同时继续为患者提供可能挽救生命的治疗。通过使用远程医疗、居家化疗和远程患者监测技术将护理带到家中，有助于在不牺牲所提供护理质量的前提下，将患者和医护人员的风险降至最低。这些护理模式在正确的时间为正确的患者提供了正确的治疗。疫情结束后，这些以患者为中心的护理模式是否会继续得到关键利益相关者的认可仍不确定。
